Atomistry » Magnesium » PDB 6ly3-6m5v » 6lzz
Atomistry »
  Magnesium »
    PDB 6ly3-6m5v »
      6lzz »

Magnesium in PDB 6lzz: Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A

Enzymatic activity of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A

All present enzymatic activity of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A:
3.1.4.35;

Protein crystallography data

The structure of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A, PDB code: 6lzz was solved by Y.Y.Huang, Y.Wu, H.B.Luo, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 21.87 / 2.40
Space group P 41 21 2
Cell size a, b, c (Å), α, β, γ (°) 103.383, 103.383, 268.366, 90, 90, 90
R / Rfree (%) 25.3 / 29.5

Other elements in 6lzz:

The structure of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A also contains other interesting chemical elements:

Zinc (Zn) 2 atoms

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A (pdb code 6lzz). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A, PDB code: 6lzz:
Jump to Magnesium binding site number: 1; 2;

Magnesium binding site 1 out of 2 in 6lzz

Go back to Magnesium Binding Sites List in 6lzz
Magnesium binding site 1 out of 2 in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg602

b:23.9
occ:1.00
O A:HOH732 1.9 23.0 1.0
O A:HOH706 2.0 24.8 1.0
O A:HOH763 2.1 20.9 1.0
OD1 A:ASP293 2.1 21.7 1.0
O A:HOH723 2.2 27.0 1.0
O A:HOH716 2.2 23.6 1.0
CG A:ASP293 3.2 23.6 1.0
OE2 A:GLU322 3.4 28.7 1.0
OD2 A:ASP293 3.7 24.9 1.0
NE2 A:HIS325 3.8 21.4 1.0
O A:HIS292 4.0 17.0 1.0
ZN A:ZN601 4.0 54.5 1.0
CD2 A:HIS325 4.1 22.4 1.0
CD2 A:HIS296 4.2 23.3 1.0
O A:HOH709 4.3 23.7 1.0
CD A:GLU322 4.3 25.3 1.0
OG1 A:THR363 4.4 19.4 1.0
NE2 A:HIS296 4.5 19.0 1.0
O A:HOH766 4.6 33.2 1.0
CB A:ASP293 4.6 22.3 1.0
NE2 A:HIS252 4.6 26.8 1.0
CG A:GLU322 4.6 22.1 1.0
CD2 A:HIS292 4.7 21.6 1.0
CD2 A:HIS252 4.8 21.8 1.0
CA A:ASP293 4.9 18.3 1.0
O A:HOH756 4.9 26.0 1.0
CE1 A:HIS325 5.0 20.3 1.0
OD2 A:ASP402 5.0 23.9 1.0
CB A:THR363 5.0 22.5 1.0

Magnesium binding site 2 out of 2 in 6lzz

Go back to Magnesium Binding Sites List in 6lzz
Magnesium binding site 2 out of 2 in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 2 of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 4A within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Mg602

b:20.2
occ:1.00
O B:HOH768 2.0 20.0 1.0
OD1 B:ASP293 2.2 24.8 1.0
O B:HOH735 2.4 17.5 1.0
O B:HOH710 2.4 19.5 1.0
O B:HOH769 2.5 33.0 1.0
O B:HOH701 2.5 18.3 1.0
CG B:ASP293 2.9 22.6 1.0
OD2 B:ASP293 3.0 24.1 1.0
ZN B:ZN601 3.3 59.1 1.0
CD2 B:HIS292 3.8 26.4 1.0
OE2 B:GLU322 4.0 21.9 1.0
OG1 B:THR363 4.1 21.7 1.0
NE2 B:HIS325 4.1 21.6 1.0
CD2 B:HIS325 4.2 19.8 1.0
O B:HIS292 4.2 33.9 1.0
CB B:ASP293 4.3 25.0 1.0
NE2 B:HIS292 4.4 29.3 1.0
OD2 B:ASP402 4.4 26.9 1.0
O B:HOH737 4.5 18.0 1.0
O B:THR363 4.6 18.0 1.0
CD2 B:HIS296 4.6 16.9 1.0
NE2 B:HIS252 4.7 26.3 1.0
CA B:ASP293 4.7 21.1 1.0
CD2 B:HIS252 4.7 24.2 1.0
CB B:THR363 4.7 24.4 1.0
CG B:GLU322 4.7 18.9 1.0
OD1 B:ASP402 4.8 27.4 1.0
CD B:GLU322 4.8 20.5 1.0
C B:HIS292 4.9 24.4 1.0
CG B:HIS292 5.0 25.0 1.0

Reference:

Y.J.Tian, Q.Zhou, P.Zhang, M.Y.Jiang, B.Zhang, X.N.Wu, C.Zhang, Z.Li, Y.Wu, Z.Chen, H.B.Luo. Identification of Phosphodiesterase-9 As A Novel Target For Pulmonary Arterial Hypertension By Using Highly Selective and Orally Bioavailable Inhibitors To Be Published.
Page generated: Tue Oct 1 10:51:02 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy